This Week in Devices [ 8/31/12]: St. Jude to Cut 300 Jobs; ICDs Endangered by Europe's Financial Crisis; Turning Your Body into a Wireless Hotspot; Libel Claim File Against the Lipotron 3000; Virtual Clinical Trials

August 31, 2012

1 Min Read
This Week in Devices [ 8/31/12]: St. Jude to Cut 300 Jobs; ICDs Endangered by Europe's Financial Crisis; Turning Your Body

ThisWeekIn.jpg
This Week in Devices [ 8/31/12]: St. Jude to Cut 300 Jobs; ICDs Endangered by Europe's Financial Crisis; Turning Your Body into a Wireless Hotspot; Libel Claim File Against the Lipotron 3000; Virtual Clinical Trials

St. Jude Medical to Cut 300 Jobs

  • St. Jude has announced it will be eliminating 300 jobs as part of a reorganization of its various medical device-making divisions. Source: Bloomberg Businessweek

Will Europe's Financial Crisis Endanger Implantable Devices?

  • Admist growing concern that the European financial crisis could lead to further underuse of implantable cardiac devices, the European Heart Rhythm Association (EHRA) has started an initiative, ICD for Life, to raise awareness about the importance of ICDs and sudden cardiac death in countries in Central and Eastern Europe. Source: Medical News Today

Turning Your Body into a Wireless Hotspot

  • Researchers say that Body Area Networks (BANs), which will provide wireless connectivity for the human body for potential telehealth applications, may be coming much sooner than we think. Source: EE Times

Libel Claim Filed over Lipotron 3000

  • We previously wrote about the Lipotron 3000, an unintrusive liposuction device that has been sold and distributed without FDA clearance. Now a medical device distributor has filed a libel claim against FairWarning, the consumer group Public Citizen, and several other parties, claiming they made false statements about the sales of the Lipotron 3000. Source: NBC News

Virtual Clinic Trials

  • Researchers at the University of Tennessee are collecting scores of data from optometry patients with the aim of creating virtual clinical trial simulations that can be accessed and used by manufacturers. Source: University of Tennessee

  

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like